HIVE Digital Technologies Ltd. (HIVE) is a stock, not an exchange-traded fund. It is a sustainable-energy-focused digital infrastructure company that operates data centers for Bitcoin mining and AI/HPC workloads, with facilities in Canada, Sweden, Paraguay, and Bermuda. Its analyst coverage remains active but divided.
This analysis reviewed seven current price targets. Canaccord Genuity's Joseph Vafi holds the highest at $10.00 (reiterated October 2026), while Chardan Capital maintains $7.50, H.C. Wainwright $7.00, Rosenblatt Securities $6.00, B. Riley Securities $6.00, Keefe, Bruyette & Woods $5.00, and Cantor Fitzgerald $4.60. The arithmetic mean is approximately $6.59, rounded to a $6.60 central target. The low-to-high range of $4.60 to $10.00 is unusually wide, reflecting genuine disagreement about HIVE's AI transition.
Reasoning differs by firm. Bullish analysts emphasize the BUZZ HPC segment and a rapidly scaling AI data center strategy. Cautious voices, including Keefe, Bruyette & Woods' Market Perform and Wall Street Zen's Sell/Strong Sell rating, focus on valuation, Bitcoin-mining economics, and execution risk. The mean should be read as a midpoint of divergent views, not a guarantee.
As of early November 2026, HIVE trades near $1.78, with a market capitalization around $488 million and a 52-week range of $1.58 to $5.34. From $1.78, the $6.60 target implies approximately 271% upside — a very large required move, well beyond typical year-ahead appreciation.
The path would depend on two overlapping drivers: a sustained rebound in Bitcoin and meaningful conversion of HIVE's AI/HPC pipeline into recurring, high-margin revenue. HIVE mined 2,311 Bitcoin in calendar 2025 (up 31% year over year), and its fiscal second-quarter revenue rose 285% year over year to $87.3 million, even as GAAP (generally accepted accounting principles) losses persisted. Notably, the $6.60 target sits above HIVE's 52-week high, meaning the stock would need to break decisively into new territory, not merely recover lost ground.
HIVE sits near the low end of its $1.58 to $5.34 52-week range. The $1.58 area represents a key support level, while the June 2026 intraday high near $5.34 acts as a notable resistance level and prior peak. Because the $6.60 target lies above that prior high, reaching it would require a breakout beyond an established ceiling — a structurally demanding setup rather than a simple retracement.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms may differ and do not always state their horizon explicitly. Investors should watch quarterly results and guidance (particularly HPC/AI revenue and margins), Bitcoin price trends and network difficulty, any new data-center or hosting contracts, changes to the at-the-market equity program, and analyst target revisions. FOMC (Federal Open Market Committee) rate decisions and broader risk appetite also influence speculative, Bitcoin-linked equities like HIVE.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis evolve. For a high-volatility name like HIVE, the service can help traders discover opportunities, track positions, and identify shifting trends more efficiently than manual screening. Traders seeking an automated, data-driven way to stay ahead of rapid changes may find these signals a useful complement to their own research.
The $6.60 central target — the mean of seven verified analyst price targets ranging from $4.60 to $10.00 — sits far above HIVE's price near $1.78 and implies a very large, roughly 271% move. The bull case rests on the AI/HPC transformation, green-energy capacity, and Bitcoin leverage, while the bear case centers on persistent losses, dilution, and crypto dependency. With targets spread from $4.60 to $10.00, analysts are clearly divided on magnitude even if most are constructive on direction. Reaching $6.60 would require a breakout above HIVE's 52-week high and sustained execution on the HPC strategy — an ambitious, not assured, outcome that investors should evaluate against their own risk tolerance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HIVE has been closely correlated with CLSK. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIVE jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To HIVE | 1D Price Change % | ||
|---|---|---|---|---|
| HIVE | 100% | -14.44% | ||
| CLSK - HIVE | 76% Closely correlated | -16.27% | ||
| KEEL - HIVE | 76% Closely correlated | -19.33% | ||
| BTBT - HIVE | 75% Closely correlated | -13.68% | ||
| CIFR - HIVE | 73% Closely correlated | -16.13% | ||
| COIN - HIVE | 73% Closely correlated | -6.34% | ||
More | ||||